Nuzenio

Pulmonary Hypertension Drug

Pulmonary Hypertension Drug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Tenax’s levosimendan fails Phase III LEVEL trial in PH-HFpEF - AllSciAllSci · Mon, 10 Aug 2026 16:40:47 GMTOrion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 13:36:28 GMTBMP3 protein identified as therapeutic target for pulmonary arterial hypertension - Drug Target ReviewDrug Target Review · Mon, 03 Aug 2026 09:49:37 GMTNew Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win - MedPage TodayMedPage Today · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 16:40:47 GMTTenax’s levosimendan fails Phase III LEVEL trial in PH-HFpEF - AllSci
Mon, 10 Aug 2026 13:36:28 GMTOrion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial - marketscreener.com
Mon, 03 Aug 2026 09:49:37 GMTBMP3 protein identified as therapeutic target for pulmonary arterial hypertension - Drug Target Review
Fri, 31 Jul 2026 07:00:00 GMTNew Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win - MedPage Today

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pulmonary Hypertension Drug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.